287 related articles for article (PubMed ID: 16983052)
21. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia.
Visser W; Beckmann I; Knook MA; Wallenburg HC
Acta Obstet Gynecol Scand; 2002 Aug; 81(8):713-9. PubMed ID: 12174154
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes.
Kinalski M; Telejko B; Kuźmicki M; Kretowski A; Kinalska I
Horm Metab Res; 2005 Jul; 37(7):450-4. PubMed ID: 16034719
[TBL] [Abstract][Full Text] [Related]
23. [Role of the TNF system in the pathomechanism of bronchial asthma].
Halász A; Cserháti E; Cseh K
Orv Hetil; 2002 Mar; 143(11):553-7. PubMed ID: 12583324
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association.
Knobler H; Zhornicky T; Sandler A; Haran N; Ashur Y; Schattner A
Am J Gastroenterol; 2003 Dec; 98(12):2751-6. PubMed ID: 14687828
[TBL] [Abstract][Full Text] [Related]
25. [Soluble TNF and IL-2 receptors in patients with breast carcinoma].
Tesarová P; Kvasnicka J; Umlaufová A; Homolková J; Jirsa M; Tesar V
Cas Lek Cesk; 1998 May; 137(11):341-5. PubMed ID: 9727208
[TBL] [Abstract][Full Text] [Related]
26. Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine.
Kraus T; Haack M; Schuld A; Hinze-Selch D; Koethe D; Pollmächer T
Pharmacopsychiatry; 2002 Nov; 35(6):220-5. PubMed ID: 12518269
[TBL] [Abstract][Full Text] [Related]
27. Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease.
Takabatake N; Nakamura H; Inoue S; Terashita K; Yuki H; Kato S; Yasumura S; Tomoike H
Respir Med; 2000 Dec; 94(12):1215-20. PubMed ID: 11192958
[TBL] [Abstract][Full Text] [Related]
28. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
[TBL] [Abstract][Full Text] [Related]
29. Increased plasma level of tumor necrosis factor α in patients with narcolepsy in Taiwan.
Chen YH; Huang YS; Chen CH
Sleep Med; 2013 Dec; 14(12):1272-6. PubMed ID: 24157100
[TBL] [Abstract][Full Text] [Related]
30. Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis.
Vaiopoulos G; Boki K; Kapsimali V; Coulocheri S; Papadaki HA; Eliopoulos GD
Haematologia (Budap); 1998; 29(2):89-99. PubMed ID: 9728801
[TBL] [Abstract][Full Text] [Related]
31. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers.
Haack M; Pollmächer T; Mullington JM
Brain Behav Immun; 2004 Jul; 18(4):361-7. PubMed ID: 15157953
[TBL] [Abstract][Full Text] [Related]
32. TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population.
Himmerich H; Fulda S; Linseisen J; Seiler H; Wolfram G; Himmerich S; Gedrich K; Pollmächer T
Eur Cytokine Netw; 2006 Sep; 17(3):196-201. PubMed ID: 17194640
[TBL] [Abstract][Full Text] [Related]
33. Drug-induced urticaria--activity of selected cytokines and acute phase proteins in plasma.
Czelej D; Chodorowska G; Lechowska-Mazur I
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):38-42. PubMed ID: 15314956
[TBL] [Abstract][Full Text] [Related]
34. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
van Riemsdijk-van Overbeeke IC; Baan CC; Hesse CJ; Loonen EH; Niesters HG; Zietse R; Weimar W
Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
[TBL] [Abstract][Full Text] [Related]
35. Expression of tumor necrosis factor-alpha and its soluble receptors in betel-quid-chewing patients at different stages of treatment for oral squamous cell carcinoma.
Su TR; Chang KL; Lee CH; Chen CH; Yang YH; Shieh TY
Oral Oncol; 2004 Sep; 40(8):804-10. PubMed ID: 15288835
[TBL] [Abstract][Full Text] [Related]
36. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight.
Shearer WT; Reuben JM; Mullington JM; Price NJ; Lee BN; Smith EO; Szuba MP; Van Dongen HP; Dinges DF
J Allergy Clin Immunol; 2001 Jan; 107(1):165-70. PubMed ID: 11150007
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock.
Iglesias J; Marik PE; Levine JS;
Am J Kidney Dis; 2003 Jan; 41(1):62-75. PubMed ID: 12500222
[TBL] [Abstract][Full Text] [Related]
38. [Effects of high-volume hemofiltration on serum levels of tumor necrosis factor and its receptors in patients with multiple organ dysfunction syndromes].
Zhang J; Tao LJ; Ning JP; Xu H; Ai YH; Zhao SP
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Feb; 16(2):81-4. PubMed ID: 14764220
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory mediators and immune function are altered in home parenteral nutrition patients.
Hise ME; Compher C; Harlan L; Kohlmeier JE; Benedict SH; Gajewski B; Brown JC
Nutrition; 2006 Feb; 22(2):97-103. PubMed ID: 16459221
[TBL] [Abstract][Full Text] [Related]
40. Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.
Sørensen LK; Havemose-Poulsen A; Bendtzen K; Holmstrup P
J Periodontol; 2009 Feb; 80(2):282-9. PubMed ID: 19186969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
